| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |